23 January 2017
News and Views
Links and Services
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner, reports March's issue of Gut.
Type 2 diabetes mellitus is associated with a higher risk of hepatocellular carcinoma, which is a
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors